N@N

Market Maker Surveillance Report. GENE, SWSH, MGT, ROSG, VRML, GNOM, Winning Stocks With Lowest Price Friction For Thursday, M

May 24, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3854 companies with "abnormal" market making, 2786 companies with positive Friction Factors and 2760 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Genetic Technologies Ltd (NASDAQ:GENE), SWISHER HYGIENE INC (OTCBB:SWSH), MGT CAPITAL INVESTMENTS INC (AMEX:MGT), ROSETTA GENOMICS LTD (NASDAQ:ROSG), VERMILLION INC (NASDAQ:VRML), COMPLETE GENOMICS INC (NASDAQ:GNOM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  GENE    $2.360    66.67%    3,058,450    52.85%    2,646,443    45.73%    412,007      1,746   
  SWSH    $0.370    21.39%    579,358      57.06%    435,635      42.91%    143,723      3,884   
  MGT     $1.250    26.60%    41,065       35.08%    40,167       34.31%    898          7       
  ROSG    $5.210    46.35%    4,220,129    48.41%    4,098,598    47.01%    121,531      233     
  VRML    $0.910    49.46%    2,089,321    53.30%    1,829,658    46.68%    259,663      2,853   
  GNOM    $0.490    26.63%    4,194,210    51.69%    3,909,479    48.18%    284,731      5,811   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows GENE with a dollar gain Thursday of $2.36000 and a Friction Factor of 1,746 shares. That means that it only took 1,746 more shares of buying than selling to move GENE higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Genetic Technologies Ltd (NASDAQ:GENE) - Genetic Technologies Limited operates as a life science company, specializing in the fields of genetics and genomics primarily in Australia. The company provides genetic testing services to human beings for disease susceptibility, parentage, individual identity, forensics, and sports performance; animals, such as dogs, horses, birds, alpacas, exotics, and zoo animals for parentage, pedigree, traits, and disease susceptibility; and plants for traits and disease susceptibility. It also offers canine reproductive services, as well as involves in licensing its non-coding DNA patents. In addition, the company offers BREVAGen, a diagnostic test that informs clinicians and patients about individual, non-familial, sporadic risk of breast cancer for women where a breast biopsy outcome is indeterminate. The company was formerly known as Duketon Goldfields N.L. and changed its name to Genetic Technologies Limited in August 2000. Genetic Technologies Limited was incorporated in 1987 and is based in Fitzroy, Australia.

SWISHER HYGIENE INC (OTCBB:SWSH) - Swisher Hygiene Inc., through its subsidiaries, provides hygiene solutions to customers in North America and internationally. It offers hygiene and facility service, such as cleaning the bowls, urinals, and sinks in a restroom; the application of a germicide to surfaces to inhibit bacteria growth; and the restocking of air-fresheners and soap dispensers. The company also engages in the power washing of restrooms and other areas; and rental and cleaning of floor mats, mops, and linens. In addition, it operates laundry processing facilities to maintain and clean rental items, such as floor mats, mops, and linens, as well as provides dust control and manual cleaning services. Further, the company develops and sells warewashing products, including cleaners and sanitizers for washing glassware, flatware, dishes, foodservice utensils, and kitchen equipment; and laundry products comprising detergents, stain removers, fabric conditioners, softeners, and bleaches in liquid, powder, and concentrated forms to clean bed linen, clothing, and table linen. Additionally, it sells, rents, leases, installs, and services dishwashing machines, pre-rinse units, chemical dispensing units, dish tables and racks, food handling and storage products, and parts, as well as various dispensing systems. The company also provides various concentrated and ready-to-use chemicals and cleaning products consisting of general purpose cleaners, disinfectants, detergents, oven and grill cleaners, general surface degreasers, floor cleaners, and specialty cleaning products. Swisher Hygiene offers its products and services through 66 company-owned locations and 12 franchises located in the United States and Canada, as well as through license agreements and independent third-party distributor partners. It serves customers in the foodservice, hospitality, retail, industrial, and healthcare industries. The company was founded in 1986 and is headquartered in Charlotte, North Carolina.

MGT CAPITAL INVESTMENTS INC (AMEX:MGT) - MGT Capital Investments, Inc., through its subsidiaries, engages in the medical imaging business in United Kingdom, other parts of Europe, the United States, Japan, and China. It develops and commercializes computer aided detection (CAD) and image analysis software, which analyzes computer tomography (CT) scans to assist radiologists in the early detection and measurement of colorectal polyps and lung lesions. The companys products include ColonCAD software, which displays CAD marks on the images focusing on potential polyps; MedicRead product, a visualisation software application for CT colonography; and MedicCO2LON, which is an automated carbon dioxide insufflation device. It also provides a Web portal containing an online sales channel for diagnostic, treatment, and surgery planning solutions. The company was formerly known as Medicsight Inc. and changed its name to MGT Capital Investments, Inc. in January 2007. MGT Capital Investments, Inc. was founded in 1999 and is based in London, the United Kingdom.

ROSETTA GENOMICS LTD (NASDAQ:ROSG) - Rosetta Genomics Ltd. develops microRNA-based diagnostic and in Israel. MicroRNAs are naturally expressed, or produced, using instructions encoded in deoxyribonucleic acid and are used in regulating protein production. The company develops microRNA-based diagnostic programs for various cancers, as well as for the identification of the origin of the primary tumor of metastases; for differentiating squamous from non squamous non-small cell lung cancer; and for differentiating mesothelioma from other carcinomas in the lung and pleura. The company also focuses on the development of body fluid-based diagnostic tests. In addition, it develops microRNA-based therapeutic products for the treatment of liver cancer. The company has a license and collaboration agreement with Prometheus Laboratories Inc. to license and sublicense certain rights related to the companys microRNA-based cancer diagnostic tests; and a collaboration agreement with CBR Institute for Biomedical Research to study the role of microRNAs in hematopoeisis. Rosetta Genomics Ltd. was founded in 2000 and is based in Rehovot, Israel.

VERMILLION INC (NASDAQ:VRML) - Vermillion, Inc. and its subsidiaries engage in the discovery, development, and commercialization of diagnostics tests that help physicians to diagnose and treat patients. The company develops novel diagnostic tests in the fields of oncology, hematology, cardiology, and womens health with the initial focus on ovarian cancer. Its lead product includes the OVA1 ovarian tumor triage test (the OVA1 Test), which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. The company has collaborations with various academic and research institutions, including The Johns Hopkins University School of Medicine; The University of Texas M.D. Anderson Cancer Center; University College London; The University of Texas Medical Branch; The Katholieke Universiteit Leuven; Clinic of Gynecology and Clinic of Oncology, Rigshospitalet; Copenhagen University Hospital; The Ohio State University Research Foundation; Stanford University; and the University of Kentucky. It also has strategic alliance agreement with Quest Diagnostics Incorporated to develop and commercialize up to three diagnostic tests. Vermillion, Inc. primarily serves clinical reference laboratories. The company was formerly known as Ciphergen Biosystems, Inc. and changed its name to Vermillion, Inc. in August 2007. Vermillion, Inc. was founded in 1993 and is based in Fremont, California.

COMPLETE GENOMICS INC (NASDAQ:GNOM) - Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. The companys Complete Genomics Analysis platform combines its proprietary human sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. Its customers include academic and government research centers, and biopharmaceutical companies. The company operates in the United States, Canada, and Europe. Complete Genomics, Inc. was founded in 2005 and is headquartered in Mountain View, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net